希少神経疾患治療の世界市場（～2026年）

• 英文タイトル：Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04460
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は希少神経疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別希少神経疾患治療の競争状況、市場シェア
・世界の希少神経疾患治療市場：種類別市場規模 2015年-2020年（生物製剤、有機化合物）
・世界の希少神経疾患治療市場：種類別市場規模予測 2021年-2026年（生物製剤、有機化合物）
・世界の希少神経疾患治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局）
・世界の希少神経疾患治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局）
・北米の希少神経疾患治療市場分析：米国、カナダ
・ヨーロッパの希少神経疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの希少神経疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の希少神経疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの希少神経疾患治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Allergan、Novartis、Bayer Aktiengesellschaft、Medtronic、Sanofi、Johnson & Johnson、Teva Pharmaceutical
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Rare Neurological Disease Treatment Market
The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Rare Neurological Disease Treatment Scope and Market Size
Rare Neurological Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rare Neurological Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Allergan
Novartis
Bayer Aktiengesellschaft
Medtronic
Sanofi
Johnson & Johnson
Teva Pharmaceutical

Market segment by Type, the product can be split into
Biologics
Organic Compounds
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rare Neurological Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Rare Neurological Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Organic Compounds
1.5 Market by Application
1.5.1 Global Rare Neurological Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Rare Neurological Disease Treatment Market Perspective (2015-2026)
2.2 Global Rare Neurological Disease Treatment Growth Trends by Regions
2.2.1 Rare Neurological Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rare Neurological Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Rare Neurological Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rare Neurological Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Rare Neurological Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Rare Neurological Disease Treatment Players by Market Size
3.1.1 Global Top Rare Neurological Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Rare Neurological Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Rare Neurological Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rare Neurological Disease Treatment Market Concentration Ratio
3.2.1 Global Rare Neurological Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rare Neurological Disease Treatment Revenue in 2019
3.3 Rare Neurological Disease Treatment Key Players Head office and Area Served
3.4 Key Players Rare Neurological Disease Treatment Product Solution and Service
3.5 Date of Enter into Rare Neurological Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Rare Neurological Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Rare Neurological Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Rare Neurological Disease Treatment Market Size by Application (2015-2020)
5.2 Global Rare Neurological Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Rare Neurological Disease Treatment Market Size (2015-2020)
6.2 Rare Neurological Disease Treatment Key Players in North America (2019-2020)
6.3 North America Rare Neurological Disease Treatment Market Size by Type (2015-2020)
6.4 North America Rare Neurological Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Rare Neurological Disease Treatment Market Size (2015-2020)
7.2 Rare Neurological Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Rare Neurological Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Rare Neurological Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Rare Neurological Disease Treatment Market Size (2015-2020)
8.2 Rare Neurological Disease Treatment Key Players in China (2019-2020)
8.3 China Rare Neurological Disease Treatment Market Size by Type (2015-2020)
8.4 China Rare Neurological Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Rare Neurological Disease Treatment Market Size (2015-2020)
9.2 Rare Neurological Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Rare Neurological Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Rare Neurological Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Rare Neurological Disease Treatment Market Size (2015-2020)
10.2 Rare Neurological Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rare Neurological Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Rare Neurological Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Rare Neurological Disease Treatment Market Size (2015-2020)
11.2 Rare Neurological Disease Treatment Key Players in India (2019-2020)
11.3 India Rare Neurological Disease Treatment Market Size by Type (2015-2020)
11.4 India Rare Neurological Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Rare Neurological Disease Treatment Market Size (2015-2020)
12.2 Rare Neurological Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Rare Neurological Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Rare Neurological Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Rare Neurological Disease Treatment Introduction
13.1.4 Pfizer Revenue in Rare Neurological Disease Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Rare Neurological Disease Treatment Introduction
13.2.4 Allergan Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Rare Neurological Disease Treatment Introduction
13.3.4 Novartis Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Bayer Aktiengesellschaft
13.4.1 Bayer Aktiengesellschaft Company Details
13.4.2 Bayer Aktiengesellschaft Business Overview
13.4.3 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Introduction
13.4.4 Bayer Aktiengesellschaft Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.4.5 Bayer Aktiengesellschaft Recent Development
13.5 Medtronic
13.5.1 Medtronic Company Details
13.5.2 Medtronic Business Overview
13.5.3 Medtronic Rare Neurological Disease Treatment Introduction
13.5.4 Medtronic Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.5.5 Medtronic Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Rare Neurological Disease Treatment Introduction
13.6.4 Sanofi Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.6.5 Sanofi Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Rare Neurological Disease Treatment Introduction
13.7.4 Johnson & Johnson Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Details
13.8.2 Teva Pharmaceutical Business Overview
13.8.3 Teva Pharmaceutical Rare Neurological Disease Treatment Introduction
13.8.4 Teva Pharmaceutical Revenue in Rare Neurological Disease Treatment Business (2015-2020)
13.8.5 Teva Pharmaceutical Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Rare Neurological Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Rare Neurological Disease Treatment Revenue
Table 3. Ranking of Global Top Rare Neurological Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rare Neurological Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Organic Compounds
Table 7. Global Rare Neurological Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Rare Neurological Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Rare Neurological Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Rare Neurological Disease Treatment Market Share by Regions (2015-2020)
Table 11. Global Rare Neurological Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Rare Neurological Disease Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Rare Neurological Disease Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Rare Neurological Disease Treatment Players
Table 18. Global Rare Neurological Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Rare Neurological Disease Treatment Market Share by Players (2015-2020)
Table 20. Global Top Rare Neurological Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Neurological Disease Treatment as of 2019)
Table 21. Global Rare Neurological Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rare Neurological Disease Treatment Product Solution and Service
Table 24. Date of Enter into Rare Neurological Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Rare Neurological Disease Treatment Market Size Share by Type (2015-2020)
Table 28. Global Rare Neurological Disease Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Rare Neurological Disease Treatment Market Size Share by Application (2015-2020)
Table 30. Global Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Rare Neurological Disease Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 34. North America Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 36. North America Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 40. Europe Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 42. Europe Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 46. China Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 48. China Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 52. Japan Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 54. Japan Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 58. Southeast Asia Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 64. India Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 66. India Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Rare Neurological Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Rare Neurological Disease Treatment Market Share (2019-2020)
Table 70. Central & South America Rare Neurological Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Rare Neurological Disease Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Rare Neurological Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Rare Neurological Disease Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Bayer Aktiengesellschaft Company Details
Table 90. Bayer Aktiengesellschaft Business Overview
Table 91. Bayer Aktiengesellschaft Product
Table 92. Bayer Aktiengesellschaft Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 93. Bayer Aktiengesellschaft Recent Development
Table 94. Medtronic Company Details
Table 95. Medtronic Business Overview
Table 96. Medtronic Product
Table 97. Medtronic Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 98. Medtronic Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 108. Johnson & Johnson Recent Development
Table 109. Teva Pharmaceutical Business Overview
Table 110. Teva Pharmaceutical Product
Table 111. Teva Pharmaceutical Company Details
Table 112. Teva Pharmaceutical Revenue in Rare Neurological Disease Treatment Business (2015-2020) (Million US$)
Table 113. Teva Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Neurological Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Organic Compounds Features
Figure 4. Global Rare Neurological Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Rare Neurological Disease Treatment Report Years Considered
Figure 9. Global Rare Neurological Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rare Neurological Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Rare Neurological Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rare Neurological Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Rare Neurological Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Neurological Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rare Neurological Disease Treatment Revenue in 2019
Figure 16. North America Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rare Neurological Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

希少疾患治療の世界市場（～2026年）

Global Rare Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04458 2020年11月20日 129Pages
当調査資料は希少疾患治療のグローバル市場について調査・分析したレポートです。種類別（オリジネーター医薬品、ジェネリック医薬品）市場規模、用途別（病院薬局、専門薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

希少内分泌疾患治療の世界市場（～2026年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04459 2020年11月20日 94Pages
当調査資料は希少内分泌疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

人獣共通感染症治療の世界市場（～2026年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY05134 2020年11月20日 93Pages
当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

キャッスルマン病治療の世界市場（～2026年）

Global Castleman Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11288 2020年11月25日 93Pages
当調査資料はキャッスルマン病治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）市場規模、用途別（病院、臨床、外来診療ユニット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

炎症性腸疾患（IBD）治療の世界市場（～2026年）

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12375 2020年11月25日 95Pages
当調査資料は炎症性腸疾患（IBD）治療のグローバル市場について調査・分析したレポートです。種類別（TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

糖尿病性神経障害治療薬の世界市場（～2026年）

Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2020-2026
MRC2-11QY11634 2020年11月25日 97Pages
当調査資料は糖尿病性神経障害治療薬のグローバル市場について調査・分析したレポートです。種類別（カプセル、丸薬、その他）市場規模、用途別（対称性ニューロパシー、焦点・多巣性ニューロパシー）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

ニューカッスル病治療の世界市場（～2026年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03968 2020年11月20日 99Pages
当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

クッシング病治療の世界市場（～2026年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11540 2020年11月25日 99Pages
当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...

感染症治療の世界市場（～2026年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12367 2020年11月25日 91Pages
当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

希少内分泌疾患治療の世界市場（～2026年） The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive. The rare endocrine …
希少疾患治療の世界市場（～2026年） A rare disease is any disease that affects a small percentage of the population. Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear. Market Analysis and Insights: Global Rare Disease Treatment Market The global Rare Dis…
クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…